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ABSTRACT
Cocaine addiction is a public health crisis without lasting treatments to prevent relapse,
and the adolescent stage of development is associated with risky behavior, such as drug use. The
gut-brain axis may be a new target for addiction treatments. Short and medium chain fatty acids
(SMCFA) are produced by bacteria in the gut and communicate to the brain, thereby influencing
drug reinforcement. This study hypothesized that SMCFA concentrations are reduced by
antibiotic-induced gut bacterial depletion and altered by cocaine self-administration in adolescent
and adult male Wistar rats. A new method of capillary electrophoresis coupled with indirect
photometric detection (CE-IPD) was utilized to estimate SMCFA concentrations in fecal samples
from ABX- and/or cocaine-experienced rats. Results suggest that some SMCFAs decline with
bacterial depletion in adults, are influenced by cocaine in adolescents, and modestly increase
over adolescence in treatment-naïve rats. SMCFA should be investigated as possible routes for
gut-brain communication in addiction.
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1
1.1

INTRODUCTION

Substance Use Disorder
Substance use disorder (SUD) is the condition by which repeated use of an addictive

substance causes physical and cognitive impairments that intervene with normal daily living
(DSM-5 2013). According to the 2020 National Survey on Drug Use and Health, SUD affects
over 40.3 million American citizens (NSDUH, et al. 2021). Among the most addictive
substances, cocaine is a psychomotor stimulant that can lead to SUD, creating a public health
crisis that affects over 5 million people in the United States (NSDUH, et al. 2021). Currently,
there is no lasting treatment for cocaine addiction that effectively prevents relapse (Fischer et al.,
2015). Novel approaches in investigating treatment options for those suffering from cocaine
addiction are therefore necessary. Recent interest in the dramatic influence of the gut on the brain
has suggested that the gut-brain axis may be a good target for new approaches to addiction
treatment (Cryan et al., 2019; Meckel & Kiraly, 2019; Russell et al., 2021; Salavrakos et al.,
2021; Simpson et al., 2021).
1.2

Gut-Brain Axis
The gut-brain axis is a bi-directional communication system between the gut and the brain.

The gut is inhabited by trillions of bacteria and various other microbes such as fungi and viral
particles (Cryan et al., 2019; Sender et al., 2016). Combined, these microbes make up the gut
microbiome, which exerts considerable influence over many physiological processes within the
host organism (Cryan et al., 2019). Disruptions to normal gut bacterial populations have been
associated with numerous neurological disorders including (but not limited to) Alzheimer’s
Disease, Parkinson’s Disease, anxiety, depression, autism spectrum disorder, attention
deficit/hyperactivity disorder, and SUD (Fung, 2020; Gkougka et al., 2022; Perez-Pardo et al.,
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2019; Russell et al., 2021; Vogt et al., 2017; Wang et al., 2019; Wong et al., 2016). Considering
SUD, experience with cocaine abuse in particular is associated with altered gut bacterial
populations in humans (Volpe et al. 2014). Research with rodent models also demonstrates that
psychomotor stimulants alter the gut bacteria (Chivero et al., 2019; Ning et al., 2017; Scorza et
al., 2019), and further demonstrates that manipulations to bacterial populations alter drugassociated behavior (Kiraly et al., 2016; Scorza et al., 2019; Suess, 2020). For example, Kiraly et
al. demonstrated that antibiotic-induced gut bacterial depletion can lead to increased cocaine
reward behavior (Kiraly et al., 2016). In our own lab, antibiotic-induced gut bacterial depletion
did not affect intravenous (i.v.) cocaine self-administration, but adult male antibiotic-treated rats
showed lower bacterial load in fecal samples and higher levels of cue-induced reinstatement of
cocaine-associated lever-pressing after 30 days of forced abstinence, compared with watertreated controls (Suess, 2020). Combined, these studies implicate a connection between gut
microbiota and drug-seeking behavior. However, there is limited research in this area and results
vary, perhaps in part due to the diversity of experimental parameters such as which antibiotics
are administered, the timing of antibiotic exposure (i.e., duration of exposure and whether
antibiotics are given during or prior to drug exposure), method of drug delivery (i.e., intravenous,
intraperitoneal, inhaled, self-administered via lever press, or passively exposed in conditioned
place preference), animal model (rats or mice), etc. Therefore, the underlying mechanisms as to
how the gut and brain interact with drug associated behavior has yet to be identified, but a
mechanism of interest is short and medium chain fatty acids (SMCFA) synthesized by gut
bacteria. This led our lab to investigate SMCFAs in fecal matter from subjects in our previous
behavioral experiments.
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1.3

SMCFAs Signal to the Brain
Short chain fatty acids (SCFAs) are the products of gut bacterial fermentation from dietary

fibers and signal to the brain to carry out numerous biological roles (Dalile et al., 2019). For
example, SCFAs influence gene transcription through the inhibition of histone deacetylases
(HDACs) (Fattahi et al., 2020), and they alter immune responses by regulating immune cells
such as neutrophils and macrophages (Corrêa-Oliveira et al., 2016). Locally in the gut, SCFAs
influence gastrointestinal (GI) motility, maintain the GI barrier (Shaidullov et al., 2021), and
exert anti-carcinogenic and anti-inflammatory properties (Carretta et al., 2021; Fattahi et al.,
2020). Therefore, disruptions to SCFA concentrations will lead to disruptions in various
physiological processes.
Three fatty acids are the most abundant as byproducts of bacterial fermentation in the
mammalian gut: acetate, butyrate, and propionate (Macfarlane & Macfarlane, 2012). The genera
of bacteria, Bacteroides, Bifidobacteria, and Eubacteria are among the main producers of
acetate, while Bacteroides produce propionate, and Eubacteria produce butyrate (Macfarlane &
Macfarlane, 2012). Additional SCFAs are formate and valerate, along with isomeric acids,
known as branched chain fatty acids, that include methyl groups in their carbon chains
(isobutyrate, isovalerate, and 2-methylbutanoate). These carboxylic acids vary in carbon chain
length from 1-5. Medium chain fatty acids include caproate, caprylate, caprate, and laurate with
chain lengths from 6-10. Less is known about medium chain fatty acids and their processes in the
mammalian gut. The present study investigated caproate, also known as hexanoic acid.
With regard to psychostimulant-related behavior, Ning and colleagues, reported that
methamphetamine alters gut bacterial composition, resulting in the observation that low levels of
propionate are associated with methamphetamine conditioned place preference in rats (Ning et
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al., 2017). Kiraly et al. demonstrated that exogenous administration of short chain fatty acids
(acetate, butyrate, and propionate) reduces cocaine conditioned place preference, thereby
reversing the effects caused by antibiotics mentioned above (Kiraly et al., 2016). The present
study used fecal matter from male rats with antibiotic treatment and/or i.v. cocaine selfadministration and cue-induced reinstatement experience from Suess et al. (2020) to explore gut
levels of SMCFA concentrations in the context of antibiotic-induced depletion of gut bacteria.
1.4

Adolescents vs. Adults: Drug Abuse and Gut Microbiota
Adolescence is a developmental phase of increased risk-taking behavior, which can include

illicit drug use, in part due to the relatively delayed maturation of the prefrontal cortex (TervoClemmens et al., 2020). Early initiation of drug abuse can lead to dramatic long-term effects
such as subsequent SUD along with other mental health comorbidities (Anthony & Petronis,
1995). Psychomotor stimulant abuse among adolescents, specifically cocaine, has been linked to
disruptions to the normal development of the brain (Kuhn et al., 2013; Squeglia et al., 2009).
Thus, the present research also considers adolescent male rats and the potential impact of
antibiotics and/or cocaine self-administration on SMCFA concentrations. In rats, cocaine intake
during adolescence can lead to heightened levels of stress-induced reinstatement of drug-seeking
behavior (Wong & Marinelli, 2016), but our own prior work shows numerous examples of
resilience among adolescents compared with adults with regard to reinstatement of drug seeking
behavior (Doherty et al. 2013; 59 Doherty and Frantz 2013; Li and Frantz 2009; (Suess, 2020))
Furthermore, adolescent male Wistar rats demonstrate a gut resiliency to antibiotics, such
that they recover faster from antibiotic-induced gut bacterial depletion and fail to show the
heighted cue-induced reinstatement of cocaine-seeking after abstinence that was demonstrated by
their adult counterparts (Suess, 2020). This dichotomy between adolescents vs. adults could be
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due to the developing gut microbiota of adolescents, which is distinct from an adult’s (Agans et
al., 2011). Research in adolescent gut development alongside the impact of cocaine is even more
sparce and therefore a deeper examination of these components of the gut from a developmental
viewpoint is warranted. Our lab sought to take preliminary steps better understand the disparity
between adolescent and adult gut composition and the impact of antibiotic exposure and/or
cocaine self-administration.
1.5

Gap in Current Knowledge: SMCFA Development, Antibiotics, and Cocaine
Adolescent development of the gut microbiota remains an overlooked area of scientific

study. Even less explored is the development of SMCFA content in the gut. The current study
hypothesized that there are developmental changes occurring in the gut during adolescence that
can be observed through fecal SMCFA concentrations.
While our prior work shows that gut bacterial depletion with antibiotic administration is
followed by a ‘rebound’ in bacterial load among adolescents but not adult male rats (Suess,
2020), we have yet to investigate the impact of antibiotics on SMCFAs in adolescent and adult
rats. This led to the second of our present hypotheses; fecal concentrations of SMCFAs will
mirror the bacterial abundance depletion induced by antibiotics in a prior experiment, such that
the magnitude and/or duration of antibiotic-associated decline in SMCFAs will be less robust in
adolescents than adults.
As summarized above, previous research has demonstrated that the drugs of abuse, such as
cocaine and methamphetamine are associated with altered gut bacterial populations in both
human participants and animal models. Additional studies show that cocaine has the ability to
alter specific gut bacterial species that are known precursors to SMCFAs such as
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Ruminococcaceae (Chivero et al., 2019; Scorza et al., 2019). This led us to our third hypothesis
that SMCFAs will be altered with cocaine self-administration.
Lastly, we investigated the impact of both antibiotics and cocaine on fecal SMCFA
concentrations with the fourth hypothesis that this double ‘insult’ will further alter SMCFA
concentrations more than antibiotics or cocaine self-administration alone. Together these
analyses will comprise a complete view of the impact of development, antibiotic intake, and
cocaine self-administration on SMCFA concentrations in the gut.

2
2.1

MATERIALS AND METHODS

Subjects and Behavioral Experimentation
Fecal pellets from male Wistar rats were collected as a part of a prior behavioral

experiment in our lab and stored at -80°C (Suess, 2020). Briefly, adolescent and adult rats
(Charles River Laboratories, Inc, Raleigh, NC, USA) arrived at Georgia State University’s
animal housing facility (postnatal day 22 for adolescents and 70-74 for adults). Animals
habituated to vivarium conditions for at least 3 days prior to any procedures, were pair housed
(2-3 per cage) in humidity and temperature-controlled cages (Optirat Gen II by Animal Care
Systems; Centennial, CO) on a reverse light cycle (12:12 hr, lights off at 07:00 hr) and had ad
libitum access to food and water. Diet consisted of Lab Diet 5001 (Standard Rodent Feed in a
pellet form). All behavioral experimentation was conducted during the dark phase. All
procedures were approved by the Georgia State University Institutional Animal Care and Use
Committee.
Animals underwent catheterization surgery to the right jugular vein in order to receive
cocaine infusions (Suess, 2020). After 3 days of surgical recovery, animals were placed in one of
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eight experimental groups (Table 1), counterbalanced by body mass. Animals in antibiotic
treatment conditions received an antibiotic ‘cocktail’ (ABX; Bacitracin 0.5 mg/ml, Neomycin
2mg/ml, and Ampicillin 1mg/ml) in their drinking water and simultaneously started their first
day of white noise training (WNT). ABX was present in drinking water throughout cocaine selfadministration but was removed at the start of a 30-day forced abstinence period. An
experimental timeline is included in Figure 1. The protocol for antibiotic preparation and
administration was adapted from prior reports (Kanhere et al., 2018; Kiraly et al., 2016).
Estimated antibiotic intake was measured by the mass of the water reservoir every 2 days and
then divided by the number of animals housed in the cage (2-3 per cage) (Figure 10).
Following the surgical recovery; animals were placed in operant conditioning chambers
(Med Associates, Inc., St. Albans, VT, USA), and acquired lever pressing behavior via WNT for
4 days, such that reinforced lever-presses in daily two-hr sessions resulted in removal of a white
noise stimulus on a fixed-ratio 1 schedule in a negative reinforcement procedure. After 4 days of
WNT, two ‘loud’ cocaine-self administration sessions were conducted, in which lever-presses
resulted in presentation of an i.v. cocaine infusion (0.36 mg/kg/ infusion) coupled with removal
of the white noise stimulus. Quiet administration (QA) conditions ensued for 10 sessions over 10
days with a drug paired cue (Figure 1 & 11). Patency was confirmed by way of i.v. infusion of
1% methohexital sodium and measured by complete loss of muscle tone within 5 s of
administration. Catheter patency was tested prior to cocaine self-administration as well as 24 hr
after the last self-administration session. Subjects that failed any patency test were eliminated
from the study.
To control for the effects of ABX intake, control subjects had only H2O in their water
reservoirs. To control for cocaine experience, some rats either underwent i.v. self-administration
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procedures with saline instead of cocaine in the syringes, or they did not experience any chamber
exposure at all.
After the self-administration phase, animals entered a 30-day forced abstinence period
during which they remained in their home cages with neither ABX nor access to cocaine selfadministration. Following the abstinence, animals underwent extinction testing during which the
animals were placed back into the operant chambers for 5 consecutive 1-hr sessions with no drug
cues or cocaine available. Immediately afterwards, animals underwent a single 1-hr
reinstatement test, in which drug-paired cues were present, but no syringe was attached, and no
cocaine was administered. Subjects were then sacrificed for organ harvesting for procedures
outside the scope of this report.

Table 1: Experimental Groups for Behavioral Testing
Peri-adolescent
Adult
H2O/no cocaine

H2O/no cocaine

ABX/no cocaine

ABX/no cocaine

H2O/cocaine

H2O/cocaine

ABX/cocaine

ABX/cocaine

9

(image adapted from (Kufahl & Olive, 2011))
Figure 1: Behavioral Experimentation

2.2

Materials
Fecal samples were collected throughout the behavioral experimentation described above.

Rats were held by the base of the tail and the back paws were gently lifted up and down while
the front paws remained on a solid surface until a fresh fecal pellet was released. When animals
were in operant chambers, fecal pellets were collected from the sterile tray under the animal.
Samples were placed on ice in a 150 µL Eppendorf tube then moved to a -80 °C freezer for
storage.
For the present analyses, fecal pellets were selected at 3 timepoints from each individual
subject in each experimental condition. The number of samples per timepoint is listed in Table 2.
To enable repeated measures analyses, each timepoint and experimental condition followed the
same set of animals. For example, rat 977 was in the adult ABX/no cocaine treatment group and
fecal samples from this specific animal were selected at each of the 3 timepoints listed.
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Timepoint 1 was after arrival to university facilities, but prior to catheterization surgery, ABX,
and/or cocaine exposure. Timepoint 2 was during cocaine (or saline) self-administration after 1114 days of ABX treatment and/or 5-9 days of cocaine intake. Timepoint 3 was after the 30-day
forced abstinence period on the day of extinction and reinstatement testing, which was
immediately followed by sacrifice. See fecal collection timeline below (Figure 2).

Table 2: Number of Samples per Timeline and Postnatal (PND) Range
Age
Experimental Samples
Timepoint Timepoint Timepoint
group
group
per
1 PND
2 PND
3 PND
timepoint
range
range
range
Periadolescent
Periadolescent
Periadolescent
Periadolescent
Adult

H2O/no
cocaine
ABX/no
cocaine
H2O/cocaine

7

ABX/cocaine

5
5

Adult

H2O/no
cocaine
ABX/no
cocaine
H2O/cocaine

Adult

ABX/cocaine

5

Adult

3

24-26

41-51

68-76

72-79

90-94

121-125

5

8
5

Figure 2: Experimental Timeline for Fecal Analysis
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2.3

Fecal Sample Desiccation Timeline Experiment
A preliminary study was conducted to determine the optimal duration of fecal pellet

desiccation for SMCFA analysis. A single fecal sample from an adult H2O/no cocaine animal
was divided into 6 subsamples of approximately 0.12 g each and placed in the desiccator. Every
2 hr for 12 hr, a subsample was taken out of the desiccator, re-weighed, and further prepared for
SMCFA analysis (described below). This desiccation timeline revealed that a plateau of water
loss occurs between 6 – 8 hr (Figure 3) and that the concentrations. The analysis also revealed
that concentrations of propionate, butyrate, and acetate (in µmol/g fecal matter) showed
significant changes between the 6 and 8 hr desiccation timepoints. No deterioration of sample
was observed in this study. Thus, a desiccation of 8 hr was deemed optimal for analysis.

Table 3: Fecal Concentrations of SMCFA Observed in
Desiccation Timeline Experiment

Figure 3: Percent of Mass Lost Over
Desiccation Time

2.4

Fecal Sample Preparation for SMCFA Analysis
After thawing, approximately 0.12 g of fecal sample was weighed, added to an Eppendorf

tube, and placed in a desiccator with 2-5 mm blue silica gel beads for 8 hr. Fecal samples were
then removed from the desiccator and weighed again to record final mass of analyzed sample.
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Then 700 µL of deionized (DI) water was added to each sample tube, and vortexed for at least 3
min or until a homogenized solution was obtained. Each tube was then centrifuged at 4800 g
(14.8x1000 rpm) at 4˚C for 20 min. Next, 500 µL of the supernatant was transferred to a
centrifuge filter tube and spun for 20 min at 4800 g (14.8x1000 rpm) at 4˚C, with this step
repeated to filter any solid fecal matter that might still be present in the collected supernatant.
The filtered supernatant was then aliquoted into 3 separate Eppendorf tubes of approximately
150 µL each and immediately stored in -80˚C freezer until further analysis.
2.5

Capillary Electrophoresis Coupled with Indirect Photometric Detection (CE-IPD)
As detailed in (Pham et al., 2021), fecal SMCFAs can be separated detected ,and quantitated

via Agilent 7100 Capillary Electrophoresis (CE) coupled with UV detection at 30kV using a
UV-absorbing buffer (100 mM boric acid at pH 6.5), alongside a visualizing reagent
(chromophore). The buffer and visualizing agent are needed because SMCFA do not have any
chromophore. Therefore, a UV-absorbing buffer [(7 mM adenosine monophosphate, (5’-AMP)]
dissolved in 100 mM boric acid and 5 mM alpha cyclodextrin at pH 6.5 facilitates peak detection
as negative peak of SMCFA. However, the negative peak can be switched to positive peak by
flipping the reference and detection wavelength on the software to allow accurate measurement
of peak area. The capillary column used was bare fused silica with a capillary length of 64.5 cm,
an average internal diameter of 75μm (356μm OD; Polymicro Technologies (Phoenix, AZ)).
Each capillary column was rinsed with 1 M NaOH for 30 min, followed by triply deionized
water for 15 min. Finally, the capillary was filled with 5-AMP buffer before injection and
running each standard and sample. This is a newly developed and validated method of
quantification that was used to determine the concentrations of several SMCFAs in rat fecal
matter, including hexanoic acid (HXA), valeric acid (VA), isovaleric acid (IVA), butyric acid
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(BA), isobutyric acid (IBA), propionic acid (PA), and acetic acid (AA). The quantification
analysis for this study utilized the internal standard method with trifluoroacetic acid (TFA) as the
internal standard to improve the precision of peak area. TFA was selected as the internal standard
based on the elution time, which is after each of the target fatty acids (FA). To establish
calibration curves, the following fatty acids were acquired: Acetic acid (AA, ACS
reagent,≥99.7%), propionic acid (PA,ACS reagent,≥99.5%), butyric acid (BA,≥99%), isobutyric
acid (IBA), Valeric acid (VA,99%), isovaleric acid (IVA, 98%) (purchased from AlfaAesar
(Haverhill, MA)) and Hexanoic acid (HxA, 99%) (Acros Organics (Fair Lawn, NJ)).
During method development and sample testing, a calibration curve (CC) was used to
estimate peak area and elution time for known quantities of each of the seven SMCFAs included
in this analysis. The calibration curve contained five concentrations to create five peaks and was
used to determine the concentration ratio of each FA, using standard mixtures (in order):
deionized water (40 µL, 34 µL, 19.6 µL, 25 µL, and 9.4 µL accordingly), 2mM of TFA for each
point, AA (0.05, 1.70, 3.35, 5.00, and 6.65 mM), PA, BA, IBA, VA, IVA, and HXA (0.05, 0.20,
0.35, 5.00, and 0.65 mM). Each point also contained, 5 µL of fecal solution from an adolescent
H2O/no cocaine rat. The adolescent H2O/no cocaine fecal sample was obtained from PND 25-27
(similar to timepoint 1) and was collected shortly after arrival to GSU and prior to any
procedures and behavioral testing. This utilization an adolescent H2O/no cocaine was determined
during method development and was due to the low concentration levels of SMCFAs and
therefore could be used for quantitation, allowing better matrix matching, and higher precision
and accuracy of sample analysis. Each FA peak was then verified by an automated spiking
method.
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Once a CC curve was established, the previously prepared, aliquoted, and frozen fecal
solutions were thawed and further prepped prior to loading. DI water, TFA, and fecal supernatant
were added to an Eppendorf tube. The volume of DI water, TFA, and fecal supernatant was
dependent on which treatment group: the mixture for adolescent and adult samples that were
H2O/no cocaine controls included 42 µL of DI water, 18 µL TFA, and 30 µL of fecal sample.
For samples from ABX and/or cocaine self-administration groups, the mixture contained 30 µL
DI water, 20 µL TFA, and 50 µL of fecal sample. Prior experimentation demonstrated that to
optimize detection, ABX treated and/or cocaine self-administration fecal concentrations of TFA
and fecal sample. To standardize calculations, these concentrations remained consistent for each
timepoint.
2.6

Calculations and Statistical Analysis
SMCFA peak area ratios were calculated into µmol/g feces, as well as the limit of

detection (LOD) and limit of quantification (LOQ) for each run were also calculated using
Microsoft Excel version 2206.
To measure for the effect of time on each experimental group, SMCFA concentrations
were analyzed using one-way repeated measures analyses of variance (ANOVAs) with the alpha
cut-off set to 0.05 for significance. Significant one-way ANOVAs were followed up by three
paired t-tests (T1 x T2, T1 xT3, T2 x T3). To analyze the different age groups for an extended
view of the impact of time on fatty acid concentrations (i.e. peri-adolescent at T1 x adult at T3),
unpaired T-tests were conducted. To determine the effects of treatment x time for the impact of
antibiotics, impact of cocaine, and impact of antibiotics combined with cocaine, two-way mixedmeasures (between-within) ANOVAs were utilized. If a two-way ANOVA resulted with a
significant interaction of p <0.05, three unpaired t-tests were then preformed to identify at which
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of the three time points was a main effect of treatment occurring (i.e. T1 H2O/no cocaine x T1
ABX/no cocaine, T2 H2O/no cocaine x T2 ABX/no cocaine, T3 H2O/no cocaine x T3 ABX/no
cocaine). Moreover, the impact of time was pursued with follow-up one-way ANOVAs and
specific t-tests as above. For the present analyses, Bonferroni’s Correction was not applied. All
statistics on fecal concentrations, including arithmetic mean calculations, along with
corresponding concentration graphs were generated using PRISM 7/GraphPad software (San
Diego, California, USA) using the latest plugin application in Prism/GraphPad (v.9.3.1).

3
3.1

RESULTS

Limits of Detection and Limits of Quantification
Due to the number of samples that required analysis, this project was broken down into

four runs of the CE-IPD machine on different dates. For each run, a limit of detection (LOD) and
a limit of quantification (LOQ) was calculated. For all four of the runs, every fatty acid fell
above the LOD and LOQ (Table 4).
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Run #

Table 4: Results of Limit of Detection and Limit of Quantification for each FA
Limit of Detection

Limit of Quantification

SMCFA

LOD (mM)

LOQ (mM)

Results per

Results per Acid

Acid
1

2

3

4

0.019 - 0.026

0.012 - 0.019

0.014 - 0.023

0.028 - 0.048

0.062 - 0.087

0.039 - 0.063

0.048 - 0.078

0.094-0.158

HXA

0.026

0.087

VA

0.019

0.062

IVA

0.020

0.066

BA

0.019

0.063

IBA

0.020

0.067

PA

0.024

0.079

HXA

0.019

0.063

VA

0.012

0.039

IVA

0.013

0.044

BA

0.013

0.045

IBA

0.014

0.048

PA

0.016

0.055

HXA

0.023

0.078

VA

0.014

0.048

IVA

0.016

0.054

BA

0.016

0.054

IBA

0.017

0.058

PA

0.021

0.069

HXA

0.048

0.158

VA

0.031

0.103

IVA

0.028

0.094

BA

0.030

0.099

IBA

0.030

0.101

PA

0.039

0.130

17
3.2

Limited Change in SMCFA Concentrations Over Adolescent Development
Adolescent concentrations of propionic acid showed a significant difference over time,

such that a one-way ANOVA was significant and follow-up t-tests showed a significant
difference between timepoint 1 and timepoint 3 (t6=2.771, p=0.0324; Figure 4. f). No other acid
showed any significant differences over time (Figure 4). Peri-adolescent concentrations at PND
68-76 at timepoint 3 were then compared to adult concentrations at PND 72-79 at timepoint 1
(Figure 5) using unpaired t-tests. These comparisons showed no significant difference for any of
the 7 acids analyzed (Figure 5). Furthermore, SMCFA concentrations among peri-adolescents
from PND 24-26 (timepoint 1) were compared to adults from PND 121-125 at timepoint 3
(Figure 6). This comparison showed significant differences between age groups for the medium
chain fatty acid, hexanoic acid (t10=4.841, p=0.0007; †††; Figure 6. a). There was also a
significance found between age groups for short chain fatty acid, valerate (t10=3.803, p=0.0035),
as well as branched chain fatty acid, isobutyrate (t10=3.027, p=0.0127; †; Figure 6. b & e).
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Figure 4: SMCFA Concentrations of H2O/No Cocaine
Peri-adolescents (a.-g) Adults (h.-n)
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Figure 5: Peri-adolescent H2O/Control subjects at Timepoint
3 Compared to Adult H2O/Control Subjects at Timepoint 1
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Figure 6: Age Difference of Peri-adolescent H2O/Control Subjects at
Timepoint 1 Comparted to Adults H2O/Control Subjects at Timepoint 3
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3.3

Antibiotic-induced Gut Bacterial Depletion is Associated with Lower SMCFA
Concentrations in Adult Rats
To test the impact of ABX on SMCFA concentrations, two-way mixed measures ANOVAs

were conducted, with treatment as the between-subjects variable (ABX vs. H2O) and time as the
repeated measure. Among peri-adolescents, the two-way interaction was significant for 2 of the
fatty acids: butyrate (F(2,16)=7.903, p=0.0041) and propionate (F(2,16)=7.445, p =0.0052; *; Figure
7. d & f). In preliminary one-way repeated measures ANOVAs on time, the adult antibiotic
treated animals showed significant differences for all the acids except isovaleric: hexanoic acid
(F(2,23)=7.268, p=0.0253), valeric acid (F(2,23)= 4.863, p=0.0426), butyric acid (F(2,23)=12.05,
p=0.0034), isobutyric acid (F(2,23)=43.59, p<0.0001), propionic acid (F(2,23)=16.08, p=0.001), and
acetic acid (F(2,23)=8.475, p=0.0093). Follow-up t-tests indicated significant differences in
timepoint 1 x timepoint 2, as well as timepoint 2 x timepoint 3, but not timepoint 1 x timepoint 3
for valeric acid, butyric acid, propionic acid, and acetic acid (# or ### for p <0.001). In two-way
mixed measures ANOVAs with treatment as the between-subjects variable (ABX vs. H2O) and
time as the repeated measure, there was a significant interaction for valeric acid (F(2,22)=3.453,
p=0.0496; *), isovaleric acid (F(2,22)=4.18, p=0.0289; *), isobutyric acid (F(2,22)=15.63, p<0.0001;
***), propionic acid (F(2,22)=11.84, p=0.0003; ***), and acetic acid (F(2,22)=3.717, p=0.0407; *).
Follow-up t-tests compared treatment groups at each timepoint to reveal significantly lower
levels of SMCFA among ABX-treated adults compared to H2O controls for all the acids at
timepoint 2. Other timepoints were not different, with one exception: an additional baseline
difference was observed for isobutyric acid at timepoint 1, despite no intended differences in
treatment protocols at that time.
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With regard to the impact of ABX on gut bacterial populations, see supplemental figures
(Figure 12) for decreases in gut bacterial abundance shown with qPCR for bacterial 16S rRNA.
By the end of experimentation, decreased abundance of gut bacteria rebounded back to baseline
for adolescents, but not adults. The HXA and IBA concentrations may reflect the bacterial
changes with antibiotic treatment, given that they did not return to baseline either a shown in
follow up t-test which revealed that timepoint 3 was significantly decreased compared to
timepoint 1.
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Figure 7: SMCFA Rat Fecal Concentrations of Antibiotic Treated Animals Compared to
H2O Controls.
Peri-adolescents (a.-g.) Adults (h.-n.)
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3.4

Cocaine Self-Administration Alters Few SMCFA Concentrations
Adolescents in the cocaine self-administration group showed a significant increase over

time in valeric acid (F(2,14)=4.907, p=0.0442), with timepoint 1 less than 3 and isobutyric acid
(F(2,14)=9.473, p=0.0316, with timepoint 2 less than 3 (#; Figure 8. b and e). In light of results in
Figure 6, which demonstrated an increase over time from timepoint 1 in adolescent controls
lower than timepoint 3 in adult controls for both VA and IBA, the present elevations among
cocaine-treated adolescents could reflect part of this developmental increase in acid
concentrations. In two-way repeated measures ANOVAs with cocaine treatment as the betweensubjects measure (cocaine vs. no cocaine controls) and time as the repeated measure, no
significant interactions were observed for any fatty acids (Figure 8 a-g). Significant main effects
of cocaine were recorded for hexanoic acid (F(1,10)=108.1, p<0.0001) where cocaine was
associated with higher levels than controls, as well as valeric acid (F(1,10)=5.261, p=0.0447) and
isobutyric acid (F(1,10)=11.63, p=0.0067) where cocaine was associated with lower levels than
controls (not marked). Adults in the cocaine self-administration group did not show any
significant changes in SMCFA concentrations over time, according to one-way ANOVAs
(Figure 8 h-n). In the two-way cocaine treatment x time ANOVAs, the interaction was
significant for isobutryric acid (F(2,16)=3.795, p=0.0448), with acid concentrations lower at each
timepoint among cocaine-treated rats compared with controls (*; Figure 8 l). Main effects of
cocaine treatment were recorded for hexanoic acid (F(1,8)=13.39, p=0.0064), isovaleric acid
(F(1,8)=8.814, p<0.0179), propionic acid (F(1,8)=6.191, p=0.0376), and acetic acid (F(1,8)=12.25,
p=0.0081), where cocaine was associated with higher levels of hexanoic acid but lower levels of
the other three acids.
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Figure 8: SMCFA Concentrations of Rat Fecal Matter in Cocaine Self-administration
Experimental Conditions Compared to H2O Controls.
Peri-adolescents (a.-g.) Adults (h.-n.)
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3.5

Combined Insult of Antibiotic Treatment and Cocaine Self-administration
Adolescents that had both ABX exposure and cocaine self-administration experience

showed a significant decrease over time for hexanoic acid, according to a t-test comparing the
two available timepoints (t(4)=5.203, p=0.0065, #). In two-way ANOVAs with treatment groups
(ABX/cocaine, ABX/no cocaine, H2O/cocaine) x time (repeated measures), hexanoic acid again
showed a significant interaction (F(2,10)=5.466, p=0.0249), confirming a decrease over time in
ABX/cocaine group but not others (Figure 9. a). Acetic acid also showed a significant interaction
(F(2,10)=4.968, p=0.0318), with significant differences between treatment groups at time 2 but not
time 1. No other acid showed any significance over time, nor a significant interaction for
adolescent animals (Figure 9). Adults that had both cocaine and ABX experience showed a
significant decrease over time with isobutyric acid concentrations (t(4)=3.059, p=0.0377; #;
Figure 9. l). No other acid showed significant differences over time (Figure 9). A significant
treatment x time interaction was identified in the level of propionic acid (F(2,15)=5.962,
p=0.0124), with unexpected treatment group differences at time 1 but not time 2 where
significance was seen between ABX/cocaine x ABX/no cocaine (not shown). This is unexpected,
as neither group has received any treatment at timepoint 1.
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Figure 9 SMCFA Concentrations of Rat Fecal Matter in ABX/Cocaine Self-administration
Experimental Conditions Compared to ABX/H2O and H2O/Cocaine Counterparts
Peri-adolescents (a.-g.) Adults (h.-n.)
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4.1

DISCUSSION

Summary
This study shows effective use of a newly developed and validated CE-IPD method in

analytical chemistry to consider the impact of adolescent development, antibiotic-induced gut
bacterial depletion, and/or i.v. cocaine self-administration on concentrations of SMCFA in fecal
matter from adolescent and adult male rats. In keeping with the new method validation (Pham et
al. 2021), SMCFA concentrations were above the limits of detection and reliable across at least
four analytical runs per fecal pellet. The behavioral assays of self-administration, extinction, and
reinstatement reported previously are also validated, with the levels of lever-pressing and
cocaine intake falling in expected ranges (Figure 12) (Suess 2020).
In terms of the present hypothesis-testing, the developmental analysis showed that only
propionic acid significantly changed over three timepoints in adolescent development, providing
partial support for the first hypothesis that developmental changes in bacterial populations will
be reflected in changes in SMCFA concentrations in fecal samples. The antibiotic analysis
demonstrated no significant decreases in any SMCFA concentrations over time for the periadolescent age group, but main effects of treatment (ABX vs. H2O) on butyrate and propionate
levels suggest impact of ABX to decrease some SMCFA when sample sizes are elevated and
time is removed from the analysis. On the other hand, the adult age group showed significant
decreases over time for 6 of the 7 fatty acids tested with one-way ANOVAs in this study and
significant differences for 5 of the 7 acids when compared to adult water-controls. The adult
ABX group also showed lasting effects for a few acids as well. These findings are consistent
with the prior behavioral experiment performed in our lab, wherein adults showed longer gut
bacterial deficits after ABX exposure than adolescents, and they provide partial support for the

29
second hypothesis that antibiotic-induced gut bacterial depletion is reflected in changes in
SMCFA concentrations The cocaine analysis showed significant differences over time in valeric
acid and isobutyric acid for peri-adolescents but no significant changes in SMCFA
concentrations among adults. Finally, the combined insult of both ABX and cocaine selfadministration demonstrated some interesting findings where the effects of antibiotics may have
been counteracted by cocaine experience in adult rats resulting in a less robust effect than
associated with antibiotics alone.
4.2

Developmental Analysis
While propionic acid was the only fatty acid to show significant developmental differences

in the present analysis of adolescents, valeric acid and isobutyric acid trended toward
significance with p values of 0.052 and 0.0675, respectively. Both VA and IBA, as well as HXA,
showed significantly higher levels in adults at PND 72-79 compared with adolescents at PND
24-26, suggesting a longer developmental trajectory of increasing some SMCFA. Propionic acid
did not show a significant difference in this comparison of adults vs. adolescents, though,
perhaps implying a possible peak that occurs around day 70 with a subsequent plateau. While not
statistically significant, the individual means gradually rose for five of the seven fatty acids
tested (HXA, VA, BA, IBA, PA) in adolescents, while IVA and AA rose from timepoint 1 to
timepoint 2 but then fell from timepoint 2 to timepoint 3. This variation could imply that IVA
and AA reach a developmental ‘peak’ earlier than the other acids. This developmental rise that
plateaus around or by postnatal day 70 was also observed when comparing adolescents to adults
at a similar PND, when the peri-adolescent age control group reached 68-76 PND/timepoint 3
and their adult counterparts were at 72-79 PND/timepoint 1. These comparisons showed no
significant difference for any of the 7 SMCFA concentrations, perhaps indicating that the
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adolescent rats had reached adult levels by the end of the present experiment. This also suggests
that the experience in the behavioral experiment among adolescents did not affect SMCFA
levels, given that the adults tested at approximately the same PND showed similar SMCFA
concentrations before the start of their experimentation.
To further explore these developmental trends, future analysis would benefit from more
experimental subjects (power of analysis) and more frequent sample collection (providing higher
temporal resolution). Other considerations could include chamber exposure and amount of
handling the animals were exposed to, i.e. whether the animal had a catheter and received saline,
or underwent a sham surgery and had chamber exposure only, or did not have any chamber
experience (housing controls). Another broad consideration is breeder handling and diet; the
animals arrived at PND 22 (for adolescents) and PND 70-74 (for adults) and the developmental
difference in breeder handling, GSU experimenter handling, and gut exposure to the breeder diet
vs. GSU diet could affect age differences in SMCFA concentrations. Lastly, this analysis does
not consider the possible differences in the development of females, and future studies would
benefit from the incorporation of both genders.
For this developmental analysis and all other comparisons herein, it is critical to note that
SCFAs are absorbed into the bloodstream via the hepatic portal vein for distribution and
physiological impact (or excretion), as well as are found in the mucosa of the gut, whereas only a
small portion of SMCFA molecules appear to be sequestered into fecal matter. Whether the
concentrations in fecal matter are proportional to those distributed for physiological impact is not
known. Sample concentrations in the blood from the portal vein as well as from the gut lining
would provide another measure but is far more invasive. A future study may consider aligning
fecal concentrations with gut and bloodstream concentrations. Moreover, any differences
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observed in fecal concentrations of SMCFAs could be explained by lower rates of production
(e.g. when SMCFA-producing bacterial populations decline) or by increased absorption of
SCFAs into the bloodstream (via the hepatic portal). Further experimentation would also be
required to differentiate these mechanisms. Finally, in terms of the new CE-IPD method, an
extension of this study could seek to align the present results with a more traditional assays such
as chemical separation by gas or liquid chromatography coupled with detection by mass
spectrometry.
4.3

Impact of Antibiotics
Antibiotic treatment was associated with significant decreases in SMCFA concentrations

that were more consistent and robust in adults, compared to adolescents. The adolescent ABXtreated rats showed no significant changes over the three timepoints, although butyric acid and
propionic acid levels were lower among ABX-treated animals at timepoint 2 (during ABXtreatment) compared with water-treated controls at that timepoint. The lack of effect over time
may be related to the initially low concentrations of SMCFAs in pre-adolescent rats upon arrival
at PND 22. ABX-related declines in butyric and propionic acid likely reflect the impact of ABX
to decrease bacterial abundance in the gut (Suess 2020), thereby eliminating bacterial producers
of these acids, such as Bacteroides, the main producer of propionate, and/or Eubacteria, the main
producer of butyrate (Macfarlane & Macfarlane, 2012). An extension of this study should
consider analyzing the gut bacteria populations of these animals to see which bacteria were
depleted by antibiotics and how this may align with the current findings.
The adult ABX-treated rats did show significant declines over time in concentrations of 6
of the 7 SMCFAs tested (all except IVA). While some acid concentrations ‘recovered’ to
baseline levels by timepoint 3 (VA, BA, PA, AA), others remained lower (HXA and IBA). This
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finding both complements and contradicts the prior experiment in this lab showing that bacterial
abundance in these ABX adults did not recover to baseline by the time of extinction and
reinstatement testing; HXA and IBA reflect this timeline, but the other five SMCFAs
investigated here did return to baseline (Figure 12). It is possible that the fatty acid results
provide clues about which bacterial populations recover to normal levels first, vs. those that
remain compromised as bacterial flora recover from ABX-insult. One noteworthy limitation of
this phase of the experiment was the potential for ABX intake to vary from subject to subject; the
ABX solution intake was measured every other day, but for each cage of two-three rats. Future
studies could consider food intake as well, examining for potential differences in overall
physiology that contribute to results like the present outcomes. Our previous study did report
daily body mass (Figure 16), which showed no significant differences across treatment groups,
implying that overall energy balance was stable. However antibiotic and/or cocaine selfadministration could potentially interrupt cycles of food consumption, etc. that exert secondary
influence on production or utilization of SMCFA.
4.4

Impact of Cocaine Self-administration
Unlike the impact of ABX treatment alone, cocaine self-administration alone was

associated with more robust effects in adolescents than adults. Cocaine experience was
associated with increases in VA and IBA over time for the adolescent age group, perhaps
implying that cocaine interrupts the normal developmental trajectory of fatty acid production
and/or excretion. This could be related to the impact of cocaine on specific profiles of the
bacterial populations in the gut, such that those producing VA and IBA are relatively more
abundant during cocaine self-administration in rats of this age group. The adult cocaineexperienced group showed no significant changes in fatty acid concentrations over time, showing
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that although cocaine shifts the overall gut bacterial profiles in adults (Figure 14), this drug does
not interfere with the overall SMCFA production, at least not as seen in fecal concentrations.
4.5

Combined Insult of Antibiotic Treatment and Cocaine Self-administration
The combined treatments of ABX and cocaine self-administration resulted in some

unexpected findings. First, given limitations in capacity to run samples for the CE-IPD analysis,
we chose only two timepoints (1 and 2) for comparison to test the hypothesis that ABX and
cocaine-combined will exert more robust effects on SMCFA concentrations. For both HXA and
AA, significantly greater decreases were observed among ABX-cocaine-experienced treatment
groups, when compared to ABX-alone or cocaine self-administration alone.
The adult group showed a significant decrease in IBA over time, and PA showed a
significant interaction to both ABX alone or cocaine self-administration alone animals. Given
that this analysis included only two time points, it was possible to observe the impact of cocaine
and ABX compared to baseline, which was not as dramatic as antibiotics alone. This observation
indicates the possibility that cocaine may have a stronger impact on the gut’s than antibiotics.
The fact that these results are less robust in adolescents than adults may contribute to our
understanding of the mechanisms mediating the less robust effect of ABX-treatment on
reinstatement of cocaine-seeking after abstinence, where we previously observed that
adolescents did not show ABX-associated elevations in reinstatement responding, but adults did.
In the absence of significant declines in most of these fatty acids, adolescent subjects may have
maintained normal levels of cocaine-related reinforcement and enduring neurological changes
that underlie reinstatement, whereas they were perhaps exacerbated by the loss of these fatty
acids in adults. There is no information on adult recovery.
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4.6

Conclusion: Interpretation of Findings
This study contributes important data on potential signaling mechanisms from the gut to

the brain, with likely influence on drug reward and reinforcement. The fact that some
developmental changes were observed further highlights the need for a better understanding of
overall typical gut development. Adults show more robust effects than adolescents to antibiotic
treatment, indicating that adolescents are more resistant to the effects of antibiotics. Adolescents
therefore may have some form of gut protection and SMCFAs could play a role in this gut
resiliency. The effects of cocaine may support this idea as well, in that adolescents show an
increase in SMCFA concentrations with cocaine treatment. The observed increase in
concentrations could indicate a protective effect, over-compensating from the cocaine insult and
may reflect a potential mechanism for gut protection in adolescents. The combination of
antibiotics and cocaine shows the powerful effects of cocaine on the gut outweighs the impact of
antibiotics, at least as observed in fecal concentrations of SMCFAs. Put together, these findings
suggest the possibility of clinical applications of SMCFAs as a potential target for treatment for
drug addiction and relapse prevention.
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5

SUPPLEMENTAL FIGURES

All supplemental figures (below) are adapted from Suess 2020. These figures were added
with the purpose to provide a more in-depth understanding of the prior behavioral experiments
preformed to which the present study is an extension of.

Figure 10: Fluid Intake
Fluid intake was measured mass of water reservoir divided by number of animals per cage (2-3).
This measurement provided an estimate of ABX intake for antibiotic treated animals

Figure 11: Cocaine Infusion Data
Total cocaine infusions were measured by cocaine infusion per lever press.
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Figure 12: Extinction and Reinstatement Lever Press Data
Animals that self-administered cocaine showed higher levels of lever pressing during
extinction and reinstatement compared to water/saline controls. Adults, but not
adolescents, that received ABX and cocaine during self-administration showed higher
numbers of lever pressing compared to no ABX groups.

Figure 13: Gut Bacterial Abundance
Gut bacterial abundance was measured in fecal samples throughout experimentation and
demonstrated depletion to bacterial abundance with antibiotic treatment that rebounded back to
baseline for adolescents (blue), but not adults (red).
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Figure 14: Gut Bacterial Diversity in Adults
The gut bacterial profiles demonstrated an overall shift in diversity with cocaine selfadministration (a.) and antibiotic intake (b.) compared to controls.

Figure 15: Gut Bacterial Diversity in Adolescents
Gut microbiota diversity shifts in cocaine self-administration adolescents compared to
control counterparts. Antibiotic intake did not demonstrate a shift in bacterial profile.
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Figure 16: Body Mass Data
Body mass was taken daily for the duration of experimentation.
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